Ireland - English - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - busulfan - film-coated tablet - 2 milligram(s) - alkyl sulfonates; busulfan

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - rabeprazole sodium, quantity: 10 mg - tablet, enteric coated - excipient ingredients: sodium stearylfumarate; purified talc; hyprolose; hypromellose; iron oxide yellow; mannitol; iron oxide red; dibutyl sebacate; hypromellose phthalate; titanium dioxide; calcium hydroxide - rabeprazole sandoz is indicated for treatment and prevention of relapse of gastro-oesophageal reflux disease; symptomatic treatment of gastro-oesophageal reflux disease; treatment of duodenal ulcers; treatment of gastric ulcers. patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.,rabeprazole sandoz is also indicated, in combination with clarithromycin and amoxycillin, for eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis; and healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: iron oxide yellow; sodium stearylfumarate; hypromellose phthalate; calcium hydroxide; hypromellose; purified talc; titanium dioxide; dibutyl sebacate; hyprolose; mannitol - rabeprazole sandoz is indicated for treatment and prevention of relapse of gastro-oesophageal reflux disease; symptomatic treatment of gastro-oesophageal reflux disease; treatment of duodenal ulcers; treatment of gastric ulcers. patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.,rabeprazole sandoz is also indicated, in combination with clarithromycin and amoxycillin, for eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis; and healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

ajanta pharma limited, india - artemether & lumefantrine tablets - uncoated tablets - 60/360

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

ajanta pharma limited, india - artemether & lumefantrine tablets - uncoated tablets - 80/480

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: magnesium stearate; methyl hydroxybenzoate; quinoline yellow; sunset yellow fcf; hypromellose; colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; hyprolose; macrogol 3350; macrogol 400 - patients with moderate to severe angina pectoris due to atherosclerotic coronary artery disease or coronary artery spasm (vasospastic angina).

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 500 mg - levetiracetam extended-release tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in patients ≥ 16 years of age with epilepsy. none teratogenic effects pregnancy category c there are no adequate and well-controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogenic effects, at doses similar to or greater than human therapeutic doses. levetiracetam extended-release tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of levetiracetam to female rats throughout pregnancy and lactation led to increased incidences of minor fetal skeletal abnormalities and retarded offspring growth pre- and/or postnatally at doses ≥ 350 mg/kg/day (approximately equivalent to the maximum recommended human dose of 3000 mg [mrhd] on a mg/m2 basis) and with increased pup mortality and offspring behavioral alterations at a dose of 1800 mg/kg/day (

Australia - English - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - paracetamol, quantity: 500 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: maize starch; croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; stearic acid; dichloromethane; isopropyl alcohol; povidone; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000; sodium citrate dihydrate - temporary relief of acute (short term) pain and / or,inflammation associated with headache, migraine,headache, tension headache, sinus pain, toothache,,dental procedures, backache, muscular aches and pains,,period pain, sore throat, tennis elbow, rheumatic pain and,arthritis, and the aches and pains associated with colds,and flu. reduces fever.

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - divalproex sodium (unii: 644vl95ao6) (valproic acid - unii:614oi1z5wi) - valproic acid 250 mg - divalproex sodium extended-release tablets are a valproate and are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features. a manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, poor judgment, aggressiveness, and possible hostility. a mixed episode is characterized by the criteria for a manic episode in conjunction with those for a major depressive episode (depressed mood, loss of interest or pleasure in nearly all activities). the efficacy of divalproex sodium extended-release tablets is based in part on studies of divalproex sodium delayed-release tablets in this indication, and was confirmed in a 3-week trial with patients meeting dsm-iv tr criteria for bipolar i disorder, manic or mixed type, who were hospitalized for acute mania [see clinical studies (

Ireland - English - HPRA (Health Products Regulatory Authority)

tillomed laboratories limited - atenolol - film coated tablet - 25 milligram - atenolol